Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds



Status:Recruiting
Healthy:No
Age Range:35 - 60
Updated:4/21/2016
Start Date:January 2016
End Date:September 2016
Contact:Michael S Singer, MD, PhD
Email:volunteers@topokine.com

Use our guide to learn which trials are right for you!

A Phase 2, Randomized, Double-blind, Placebo-controlled Study of TAT4 Gel for the Reduction of Nasolabial Folds

This is a Phase 2, randomized, double-blind, placebo-controlled study of TAT4 Gel for the
reduction of moderate to severe nasolabial folds.


Inclusion Criteria:

- Moderate to severe, bilateral nasolabial folds

- Must understand and provide informed consent

Exclusion Criteria:

- Pregnant or lactating women

- History of skin hypersensitivity of atopic dermatitis

- Any illness of disease that, in the investigator's opinion, would make trial
participation inadvisable
We found this trial at
1
site
Boston, Massachusetts
?
mi
from
Boston, MA
Click here to add this to my saved trials